Great West Life Assurance Co. Can Has $51.23 Million Stake in Colgate-Palmolive Company (CL)
Great West Life Assurance Co. Can reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 33.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 691,866 shares of the company’s stock after selling 352,402 shares during the quarter. Great West Life Assurance Co. Can owned 0.08% of Colgate-Palmolive worth $51,229,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive in the first quarter valued at about $102,000. Proficio Capital Partners LLC boosted its stake in Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after buying an additional 207 shares in the last quarter. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive in the second quarter valued at about $109,000. Hanson & Doremus Investment Management boosted its stake in Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after buying an additional 70 shares in the last quarter. Finally, Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at about $121,000. 73.10% of the stock is currently owned by institutional investors.
WARNING: This report was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/24/great-west-life-assurance-co-can-has-51-23-million-stake-in-colgate-palmolive-company-cl.html.
Several analysts recently weighed in on CL shares. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a research note on Tuesday, July 4th. Bank of America Corporation raised their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Friday, June 30th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price objective on shares of Colgate-Palmolive in a research note on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $75.83.
Colgate-Palmolive Company (CL) opened at 71.19 on Friday. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The firm has a 50-day moving average price of $71.58 and a 200 day moving average price of $73.27. The company has a market capitalization of $62.71 billion, a P/E ratio of 26.45 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same period in the prior year, the business earned $0.70 EPS. The company’s revenue for the quarter was down .5% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
In related news, insider Patricia Verduin sold 3,833 shares of the stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $72.41, for a total transaction of $277,547.53. Following the completion of the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $3,839,323.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Vice Chairman Franck J. Moison sold 35,000 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $71.52, for a total value of $2,503,200.00. Following the sale, the insider now owns 201,411 shares of the company’s stock, valued at $14,404,914.72. The disclosure for this sale can be found here. Insiders sold a total of 217,969 shares of company stock valued at $15,693,933 over the last quarter. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.